Dr. Dick Brashier is an experienced medical writer, researcher, and regulatory advisor in the field of Experimental and Clinical Pharmacology. With a Doctor of Medicine in Pharmacology from the University of Poona in India, his post-doctoral studies include the Indian Armed Forces Medical College Dept of Pharmacology and multiple CME certification courses at Harvard Medical School.
Dr. Brashier’s expertise in pharmacovigilance (PV) and clinical research (CR) informs his work in postgraduate training and regulatory document oversight in affiliation with the EMA, PMDA, and FDA. In this capacity, he has authored publications in diverse therapeutic areas, including endocrinology, oncology, vaccines, respiratory medicine, and infectious disease.
As a highly accredited researcher, Dr. Brashier also holds CME certifications from such leading agencies as the ECFMG (Educational Commission for Foreign Medical Graduates), ACRP(Association of Clinical Research Professionals), and ACMA (Accreditation Council for Medical Affairs). He is an esteemed member of the American College of Clinical Pharmacology Society and is recognized as a pioneer in the area of PV for his contributions to Adverse Drug Reaction (ADR) monitoring protocols in Indian military hospitals.
In his lengthy career as a medical writer and editor, Dr. Brashier has been responsible for scholarly publications, educational materials, regulatory submissions, and clinical trial protocols. He has led and reported on vanguard studies in the burgeoning discipline of peptide therapeutics and now brings his formidable training, knowledge, and talent to Peptides.org as a distinguished medical content creator and pharmacology advisor.
